COPD Clinical Trial
— COPDOfficial title:
Mechanisms of Exercise Intolerance in Chronic Obstructive Pulmonary Disease
Verified date | June 2016 |
Source | Rigshospitalet, Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: Danish Dataprotection Agency |
Study type | Interventional |
1: Is endothelium function impaired in COPD? Other chronic cardiovascular diseases are
associated with endothelial dysfunction, and the endothelium plays an important role in
regulating vascular tone, tissue blood flow, coagulation and the inflammation process.
Although the specific causes of endothelial dysfunction remain unclear, physical inactivity,
chronic systemic inflammation and smoking are all known to be associated with endothelial
abnormality.
2. Is Muscular Sympathetic Nerve Activity (MSNA) increased in COPD? A balanced regulation of
blood flow to skeletal muscles may be disturbed by pathophysiology and may therefore
contribute to the exercise intolerance and skeletal muscle depletion seen in patients with
COPD.Skeletal muscle blood flow is tightly regulated to match tissue oxygen demands and is
thus adapted to meet energy requirements. During physical activity, the sympathetic nervous
system is activated ("exercise pressor reflex"), resulting in increased ventilation, heart
rate and a redistribution of cardiac output from inactive to active tissues. The
redistribution of cardiac output to the body organs is heterogeneous. Blood flow to
skeletal, respiratory and cardiac muscle increases as exercise intensity increases, whereas
blood flow to gastrointestinal, renal and reproductive tissues decreases. As blood pressure
during exercise remains largely unchanged, the redistribution of blood flow is caused by
changes in vascular conductance. These conductance changes are caused by an overall
vasoconstriction induced by the increased sympathetic outflow of noradrenaline (NA), and a
vasodilation of vascular beds supplying the working skeletal -, cardiac- and respiratory
muscle.
Status | Completed |
Enrollment | 18 |
Est. completion date | May 2016 |
Est. primary completion date | May 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Forced Expiratory Volume at on second/ Forced Vital Capacity fixed ratio <0.70, - Forced Expiratory Volume at one second <60% of predicted and Medical - Research Council scale > or equal to 3 - Arterial oxygen saturation at rest> 90%, - Body Mass Index >18, - Left Ventricle Ejection Fraction> 45. Exclusion Criteria: - Unstable ischemic heart disease, - severe heart valve failure, - pulmonary emboli, - severe heart failure, - severe infections, - musculoskeletal disorders, - malignant disease, - contraindicated medicine as anticoagulants. |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
Denmark | Centre of Physical Activity Research | Copenhagen | Capital Region |
Lead Sponsor | Collaborator |
---|---|
Rigshospitalet, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Endothelium function during acute exercise (one legged kicking) by Flow doppler | Flow doppler | On one experimental day during acute exercise (one legged knicking) and change from baseline | No |
Primary | Muscular Sympathetic Nerve Activity During acute exercise (handgrip and leg isometric leg extension) by Peroneal microneurography | On one experimental day during acute exercise (handgrib and leg isometric leg extension) and change from baseline | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06000696 -
Healthy at Home Pilot
|
||
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT04105075 -
COPD in Obese Patients
|
||
Recruiting |
NCT05825261 -
Exploring Novel Biomarkers for Emphysema Detection
|
||
Active, not recruiting |
NCT04075331 -
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
|
Phase 2/Phase 3 | |
Terminated |
NCT03640260 -
Respiratory Regulation With Biofeedback in COPD
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|
||
Withdrawn |
NCT04210050 -
Sleep Ventilation for Patients With Advanced Hypercapnic COPD
|
N/A | |
Terminated |
NCT03284203 -
Feasibility of At-Home Handheld Spirometry
|
N/A | |
Recruiting |
NCT06110403 -
Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06040424 -
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Recruiting |
NCT04868357 -
Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program
|
N/A | |
Completed |
NCT01892566 -
Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
|
N/A | |
Completed |
NCT04119856 -
Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD
|
N/A | |
Completed |
NCT04485741 -
Strados System at Center of Excellence
|
||
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT04860375 -
Multidisciplinary Management of Severe COPD
|
N/A |